Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Umezawa, Y."" wg kryterium: Autor


Tytuł:
Long‐term efficacy and safety results from an open‐label phase III study (UNCOVER‐J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab.
Autorzy:
Umezawa, Y.
Torisu‐Itakura, H.
Morisaki, Y.
ElMaraghy, H.
Nakajo, K.
Akashi, N.
Saeki, H.
Akasaka, Toshihide
Asano, Yoshihide
Etoh, Takafumi
Fujita, Yasuyuki
Hashimoto, Takashi
Higashiyama, Mari
Igarashi, Atsuyuki
Ihn, Hironobu
Iwatsuki, Keiji
Kabashima, Kenji
Kawada, Akira
Kawashima, Makoto
Nakamura, Koichiro
Pokaż więcej
Temat:
PSORIASIS
MEDICAL care surveys
ADVERSE health care events
Źródło:
Journal of the European Academy of Dermatology & Venereology; Mar2019, Vol. 33 Issue 3, p568-576, 9p
Czasopismo naukowe
Tytuł:
Long-term clinical safety and efficacy of brodalumab in the treatment of Japanese patients with moderate-to-severe plaque psoriasis.
Autorzy:
Umezawa, Y.
Nakagawa, H.
Niiro, H.
Ootaki, K.
Pokaż więcej
Temat:
PSORIASIS treatment
PSORIATIC arthritis
INTERLEUKINS
MONOCLONAL antibodies
ADVERSE health care events
RANDOMIZED controlled trials
Źródło:
Journal of the European Academy of Dermatology & Venereology; Nov2016, Vol. 30 Issue 11, p1957-1960, 4p
Czasopismo naukowe
Tytuł:
Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation.
Autorzy:
Umezawa, Y.
Kakihana, K.
Oshikawa, G.
Kobayashi, T.
Doki, N.
Sakamaki, H.
Ohashi, K.
Pokaż więcej
Temat:
VARICELLA-zoster virus
STEM cell transplantation
DISEASE risk factors
ACYCLOVIR
GRAFT versus host disease
Źródło:
Transplant Infectious Disease; Apr2014, Vol. 16 Issue 2, p195-202, 8p
Czasopismo naukowe
Tytuł:
Seasonal shifts in the contributions of the Changjiang River and the Kuroshio Current to nitrate dynamics in the continental shelf of the northern East China Sea based on a nitrate dual isotopic composition approach.
Autorzy:
Umezawa, Y.
Yamaguchi, A.
Ishizaka, J.
Hasegawa, T.
Yoshimizu, C.
Tayasu, I.
Yoshimura, H.
Morii, Y.
Aoshima, T.
Yamawaki, N.
Pokaż więcej
Temat:
NITRATES
CONTINENTAL shelf
FOOD chains
OXYGEN isotopes
PHYTOPLANKTON
MARINE phytoplankton
Źródło:
Biogeosciences; 2014, Vol. 11 Issue 4, p1297-1317, 21p, 3 Charts, 9 Graphs, 1 Map
Terminy geograficzne:
YANGTZE River (China)
Czasopismo naukowe
Tytuł:
Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection.
Autorzy:
Saeki, H.
Ito, T.
Hayashi, M.
Fukuchi, O.
Umezawa, Y.
Nobeyama, Y.
Teruya, K.
Nakagawa, H.
Pokaż więcej
Temat:
PSORIASIS treatment
HIV-positive persons
ADALIMUMAB
MONOCLONAL antibodies
HEALTH status indicators
THERAPEUTICS
Źródło:
Journal of the European Academy of Dermatology & Venereology; Aug2015, Vol. 29 Issue 8, p1653-1655, 3p
Czasopismo naukowe
Tytuł:
Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity.
Autorzy:
Umezawa, Y.
Ozawa, A.
Kawasima, T.
Shimizu, H.
Terui, T.
Tagami, H.
Ikeda, S.
Ogawa, H.
Kawada, A.
Tezuka, T.
Igarashi, A.
Harada, S.
Pokaż więcej
Temat:
PSORIASIS
THERAPEUTICS
DRUG efficacy
SKIN diseases
PHARMACODYNAMICS
CLINICAL medicine
MEDICAL literature
Źródło:
Archives of Dermatological Research; Apr2003 Supplement 1, Vol. 295, pS43-S54, 12p
Czasopismo naukowe
Tytuł:
Seasonality in nutrient concentrations and stable isotope ratios of Halophila ovalis growing on the intertidal flat of SW Thailand.
Autorzy:
Yamamuro, M.
Umezawa, Y.
Koike, I.
Pokaż więcej
Źródło:
Limnology; Dec2001, Vol. 2 Issue 3, p199-205, 7p
Czasopismo naukowe
Tytuł:
Therapeutic effect of granulocyte colony-stimulating factor and cephem antibiotics against experimental infections in neutropenic mice induced by cyclophosphamide.
Autorzy:
Wakivama, H.
Tsuru, S.
Hata, N.
Shinomiya, M.
Shinomiya, N.
Noritake, M.
Umezawa, Y.
Rokutanda, M.
Pokaż więcej
Temat:
INFECTION
ANTI-infective agents
ANTIBIOTICS
THERAPEUTICS
LEUCOCYTES
KILLER cells
Źródło:
Clinical & Experimental Immunology; May1993, Vol. 92 Issue 2, p218-224, 7p
Czasopismo naukowe
Tytuł:
In Commemoration of the 150th Anniversary of the Department of Chemistry, School of Science, The University of Tokyo-Its Past and Future.
Autorzy:
Umezawa, Y.
Pokaż więcej
Źródło:
Chemistry - An Asian Journal; Jul2011, Vol. 6 Issue 7, p1636-1637, 2p
Czasopismo naukowe
Tytuł:
A Case of TAFRO Syndrome Developed after COVID-19 Vaccination.
Autorzy:
Hirose H; Department of Nephrology, Juntendo University Urayasu Hospital, Chiba, Japan.
Suzuki H; Department of Nephrology, Juntendo University Urayasu Hospital, Chiba, Japan.; Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Umezawa Y; Department of Nephrology, Juntendo University Urayasu Hospital, Chiba, Japan.
Iwasaki M; Department of Nephrology, Juntendo University Urayasu Hospital, Chiba, Japan.
Fukuda H; Department of Nephrology, Juntendo University Urayasu Hospital, Chiba, Japan.
Takahara H; Department of Nephrology, Juntendo University Urayasu Hospital, Chiba, Japan.
Tomita S; Department of Pathology, Juntendo University Urayasu Hospital, Chiba, Japan.
Suzuki Y; Department of Nephrology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Case reports in nephrology [Case Rep Nephrol] 2023 Dec 04; Vol. 2023, pp. 7292895. Date of Electronic Publication: 2023 Dec 04 (Print Publication: 2023).
Typ publikacji:
Case Reports
Raport
Tytuł:
Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy alone.
Autorzy:
Kanao K; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka-City, Saitama-Pref, Japan.
Takahashi T; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka-City, Saitama-Pref, Japan.
Umezawa Y; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka-City, Saitama-Pref, Japan.
Okabe T; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka-City, Saitama-Pref, Japan.
Kaneko G; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka-City, Saitama-Pref, Japan.
Shirotake S; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka-City, Saitama-Pref, Japan.
Nishimoto K; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka-City, Saitama-Pref, Japan.
Oyama M; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka-City, Saitama-Pref, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Oct 20; Vol. 17 (10), pp. e0276081. Date of Electronic Publication: 2022 Oct 20 (Print Publication: 2022).
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Abiraterone Acetate*/therapeutic use
Prostatic Neoplasms*/pathology
Humans ; Male ; Androgen Antagonists/therapeutic use ; Androgens ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Prostate-Specific Antigen/therapeutic use ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results.
Autorzy:
Okubo Y; Department of Dermatology, Tokyo Medical University, Tokyo, Japan.
Umezawa Y; Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan.
Sakurai S; UCB Pharma, 8 Chome-17-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan. .
Hoshii N; UCB Pharma, 8 Chome-17-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Nakagawa H; Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2022 Jun; Vol. 12 (6), pp. 1397-1415. Date of Electronic Publication: 2022 May 27.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
A Rare Case of Radiation-Induced Liver Disease in Treated Abdominal Lymphoma Showing High [ F]FDG Avidity and Low EOB Uptake Proportional to the Irradiation Dose.
Autorzy:
Usami A; Department of Radiation Therapeutics and Oncology, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Yokoyama K; Department of Diagnostic Radiology and Nuclear Medicine, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Tsuchiya J; Department of Diagnostic Radiology and Nuclear Medicine, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Umezawa Y; Department of Hematology, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Toda K; Department of Radiation Therapeutics and Oncology, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Tateishi U; Department of Diagnostic Radiology and Nuclear Medicine, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Yoshimura R; Department of Radiation Therapeutics and Oncology, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Pokaż więcej
Źródło:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2022 Feb 16; Vol. 12 (2). Date of Electronic Publication: 2022 Feb 16.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Successful treatment with bortezomib for refractory fever associated with myelodysplastic syndrome with underlying lymphoplasmacytic lymphoma.
Autorzy:
Motomura Y; Department of Hematology Ome Municipal General Hospital Tokyo Japan.
Umezawa Y; Department of Hematology Tokyo Medical and Dental University Tokyo Japan.
Arimatsu T; Department of Hematology Ome Municipal General Hospital Tokyo Japan.
Okada K; Department of Hematology Ome Municipal General Hospital Tokyo Japan.
Miura O; Department of Hematology Tokyo Medical and Dental University Tokyo Japan.
Kumagai T; Department of Hematology Ome Municipal General Hospital Tokyo Japan.
Pokaż więcej
Źródło:
Clinical case reports [Clin Case Rep] 2022 Feb 09; Vol. 10 (2), pp. e05372. Date of Electronic Publication: 2022 Feb 09 (Print Publication: 2022).
Typ publikacji:
Case Reports
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies